These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7380764)
21. [Prevention of hospital infection: the compromised host and drug-resistant bacteria]. Shimizu K Kango Tenbo; 1987 Sep; 12(10):980-2. PubMed ID: 3682913 [No Abstract] [Full Text] [Related]
22. [The in vitro activity of 4 aminosides on gram-negative bacteria]. Ben Chaabane T; Ben Redjeb S; Bouzouia N; Kechrid A; Ben Salem N; Zribi A; Boujnah A Tunis Med; 1984 Dec; 62(8):591-4. PubMed ID: 6531815 [No Abstract] [Full Text] [Related]
23. [Characteristics of the composition of the causative agents of different forms of suppurative inflammatory diseases and their antibiotic sensitivity]. Levina EN; Kuznetsova SM; Samoĭlova LN; Speranskaia ON; Sinitsina GG Antibiot Med Biotekhnol; 1985 Sep; 30(9):681-4. PubMed ID: 3933419 [TBL] [Abstract][Full Text] [Related]
24. [Resistance of gram-negative bacilli to 6 aminoglycosides]. Broussain MT; Pinto ME; Cona E Rev Med Chil; 1985 Dec; 113(12):1210-6. PubMed ID: 3016857 [No Abstract] [Full Text] [Related]
25. A laboratory assessment of the activities of four aminoglycosides. Schrire L; Robinson RG; Koornhof HJ S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of extrachromosomal drug resistance. The role of drug-resistant and drug-selected bacteria in nosocomial disease. Isenberg HD; Berkman JI Ann N Y Acad Sci; 1971 Jun; 182():52-8. PubMed ID: 5285296 [No Abstract] [Full Text] [Related]
27. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground. Shakil S; Khan R; Zarrilli R; Khan AU J Biomed Sci; 2008 Jan; 15(1):5-14. PubMed ID: 17657587 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of cefoxitin, alone and in combination with aminoglycoside or other beta-lactam antibiotics against common gram-negative pathogens. Markowitz SM; Sibilla DJ Chemotherapy; 1983; 29(2):89-98. PubMed ID: 6839865 [TBL] [Abstract][Full Text] [Related]
29. Trends in bacterial susceptibility to antimicrobial agents. Lane MM; Parker DE; Flournoy DJ Chemotherapy; 1985; 31(6):433-9. PubMed ID: 3935395 [TBL] [Abstract][Full Text] [Related]
30. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Daneman N; Sarwar S; Fowler RA; Cuthbertson BH; Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693 [TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones. Molinari G; Schito GC Drugs; 1995; 49 Suppl 2():222-5. PubMed ID: 8549310 [No Abstract] [Full Text] [Related]
34. Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility. Eltahawy AT J Chemother; 1997 Dec; 9(6):403-10. PubMed ID: 9491839 [TBL] [Abstract][Full Text] [Related]